The role of diffusion-weighted MR imaging in diagnosis of bladder cancer

Tumor

Volumn 32, Issue 12, 2012, Pages 1025-1029

  Zhang, Lian Hua ^a   Zhu, Yin Jie ^a   Bo, Juan Jie ^a   Liu, Dong Ming ^a   Huang, Yi Ran ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apparent diffusion coefficient; Diagnostic imging; Magnetic resonance imaging; Urinary bladder neoplsams

Indexed keywords

APPARENT DIFFUSION COEFFICIENT; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CYSTITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINALYSIS;

EID: 84876903052     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2012.12.013     Document Type: Article

References (13)

1. BRAUSI M, WITJES J A, LAMM D, et al. A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group[J]. J Urol, 2011, 186(6):2158-2167.
2. TAKEUCHI M, SASAKI S, ITO M, et al. Urinary bladder cancer : diffusion-weighted MR imaging - accuracy for diagnosing T stage and estimating histologic grade[J]. Radiology, 2009, 251(1):112-121.
3. LAMBREGTS D M, MAAS M, CAPPENDIJK V C, et al. Whole-body diffusion-weighted magnetic resonance imaging: current evidence in oncology and potential role in colorectal cancer staging[J]. Eur J Cancer, 2011, 47(14):2107-2116.
4. MUELLER-LISSE U G, MUELLER-LISSE U L, ZAMECNIK P, et al. Diffusion-weighted MRI of the prostate[J]. Radiology, 2011, 51(3):205-214.
5. TAN C H, WANG J, KUNDRA V. Diffusion weighted imaging in prostate cancer[J]. Eur Radiol, 2011, 21(3):593-603.
6. GIANNARINI G, PETRALIA G, THOENY H C. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature[J]. Eur Urol, 2012, 61(2):326-340.
7. SHINAGARE A B, SADOW C A, SAHNI V A, et al. Urinary bladder: normal appearance and mimics of malignancy at CT urography[J]. Cancer Imaging, 2011, 11:100-108.
8. MOSES K A, ZHANG J, HRICAK H, et al. Bladder cancer imaging: an update[J]. Curr Opin Urol, 2011, 21(5):393-397.
9. DIGHE M K, BHARGAVA P, WRIGHT J. Urinary bladder masses: techniques, imaging spectrum, and staging[J]. J Comput Assist Tomogr, 2011, 35(4):411-424.
10. MATSUKI M, INADA Y, TATSUGAMI F, et al. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results[J]. Eur Radiol, 2007, 17(1):201-204
11. KILIÇKESMEZ O, CIMILLI T, INCI E, et al. Diffusion-weighted MRI of urinary bladder and prostate cancers[J]. Diagn Interv Radiol, 2009, 15(2):104-110.
12. VAN DEN BOSCH S, ALFRED WIGJES J. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review[J]. Eur Urol, 2011, 60(3):493-500.
13. BABJUK M, OOSTERLINCK W, SYLVESTER R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update[J]. Eur Urol, 2011, 59(6): 997-1008.